CN102048863A - Traditional Chinese medicine for treating lumbar hyperosteogeny - Google Patents

Traditional Chinese medicine for treating lumbar hyperosteogeny Download PDF

Info

Publication number
CN102048863A
CN102048863A CN2010105792278A CN201010579227A CN102048863A CN 102048863 A CN102048863 A CN 102048863A CN 2010105792278 A CN2010105792278 A CN 2010105792278A CN 201010579227 A CN201010579227 A CN 201010579227A CN 102048863 A CN102048863 A CN 102048863A
Authority
CN
China
Prior art keywords
parts
radix
chinese medicine
treatment
rhizoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010105792278A
Other languages
Chinese (zh)
Inventor
王丽华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2010105792278A priority Critical patent/CN102048863A/en
Publication of CN102048863A publication Critical patent/CN102048863A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine for treating lumbar hyperosteogeny, belonging to the technical field of treatment in orthopedics and traumatology. The traditional Chinese medicine is characterized by being prepared from the following traditional Chinese medicinal materials in parts by weight: 10-20 parts of araliae cordatae, 10-20 parts of teasel, 10-20 parts of radix achyranthis bidentatae, 25-35 parts of erythrina bark, 15-25 parts of radix gentianae macrophyllae, 8-14 parts of eucommia bark, 8-15 parts of radix clematidis, 8-15 parts of radix angelicae sineinsis, 8-14 parts of pheretima, 10-15 parts of morinda root, 6-12 parts of cibot rhizome, 6-12 parts of drynaria and 6-12 parts of raw liquorice. Based on the pathological principles of lumbar hyperosteogeny disease and the causes thereof, a pure traditional Chinese medicine formula is adopted, and active components are extracted to be prepared into oral liquid, or powder, or tablets, or capsules. After being taken, the traditional Chinese medicine can effectively treat the lumbar hyperosteogeny disease and achieve an ideal effect.

Description

A kind of Chinese medicine for the treatment of lumbar vertebra hyperosteogeny
Technical field:
The present invention relates to orthopedics department treatment field, relate in particular to a kind of technical field of Chinese medicines for the treatment of lumbar vertebra hyperosteogeny.
Background technology:
Lumbar vertebra hyperosteogeny is the common a kind of diseases of person in middle and old age, brings stress, health misery and financial burden for countless patients.
At present, the medicine of treatment lumbar vertebra hyperosteogeny disease has Chinese medicine, Western medicine, but curative effect does not all make patient satisfaction.According to pathogenic factor, the pathological change of lumbar vertebra hyperosteogeny, through investigation in many ways, textual criticism repeatedly, scientific validation learns, causes the reason of lumbar vertebra hyperosteogeny to mainly contain following several situation: the one, seat does not rise for a long time, and health blood can not normal circulation; The 2nd, be subjected to external force pressure, cause the variation of health skeleton; The 3rd, self bad habit causes lumbar vertebra hyperosteogeny; The 4th, work and living environment influence lumbar vertebra proper motion etc.
Summary of the invention:
The technical problem to be solved in the present invention is to overcome the deficiency that prior art exists, and provide a kind of Chinese patent medicine for the treatment of lumbar vertebra hyperosteogeny, can not cure the reality of lumbar vertebra hyperosteogeny at existing medicine at all, the present invention adopts traditional pure Chinese medicine, take for the patient with oral liquid, powder, tablet, capsular form, simultaneously, also, can effectively treat dissimilar lumbar vertebra hyperosteogeny diseases with stifling mode external.
The present invention is for solving the problems of the technologies described above, take to implement following technical scheme: a kind of Chinese medicine for the treatment of lumbar vertebra hyperosteogeny, it is characterized in that, it is that Chinese crude drug by following composition by weight is prepared from: 10 1 20 parts of Rhizoma et Radix Araliae Cordatae, 10 1 20 parts of Radix Dipsacis, 10 1 20 parts of Radix Achyranthis Bidentataes, 25 1 35 parts of Cortex erythrinaes, 15 1 25 parts of RADIX GENTIANAE MACROPHYLLAEs, 8 one 14 parts of Cortex Eucommiaes, 8 one 15 parts of Radix Clematidis, 8 one 15 parts of Radix Angelicae Sinensis, 8 one 14 parts of LUMBRICUS, 10 1 15 parts of Radix Morindae Officinaliss, 6 one 12 parts of gold Rhizoma Cibotii, 6 one 12 parts of Rhizoma Drynariae, 6 one 12 parts of Radix Glycyrrhizae.
The Chinese medicine of above-mentioned treatment lumbar vertebra hyperosteogeny, it is that Chinese crude drug by following preferred composition by weight is prepared from: 11 1 19 parts of Rhizoma et Radix Araliae Cordatae, 11 1 19 parts of Radix Dipsacis, 11 1 19 parts of Radix Achyranthis Bidentataes, 26 1 34 parts of Cortex erythrinaes, 16 1 24 parts of RADIX GENTIANAE MACROPHYLLAEs, 9 one 13 parts of Cortex Eucommiaes, 9 one 14 parts of Radix Clematidis, 9 one 14 parts of Radix Angelicae Sinensis, 9 one 13 parts of LUMBRICUS, 11 1 14 parts of Radix Morindae Officinaliss, 7 one 11 parts of gold Rhizoma Cibotii, 7 one 11 parts of Rhizoma Drynariae, 7 one 11 parts of Radix Glycyrrhizae.
The Chinese medicine of above-mentioned treatment lumbar vertebra hyperosteogeny, it is that Chinese crude drug by the composition by weight of following the best is prepared from: 15 parts of Rhizoma et Radix Araliae Cordatae, 15 parts of Radix Dipsacis, 15 parts of Radix Achyranthis Bidentataes, 30 parts of Cortex erythrinaes, 20 parts of RADIX GENTIANAE MACROPHYLLAEs, 10 parts of Cortex Eucommiaes, 10 parts of Radix Clematidis, 10 parts of Radix Angelicae Sinensis, 10 parts of LUMBRICUS, 10 parts of Radix Morindae Officinaliss, 8 parts of gold Rhizoma Cibotii, 8 parts of Rhizoma Drynariae, 8 parts of Radix Glycyrrhizae.
The Chinese medicine of above-mentioned treatment lumbar vertebra hyperosteogeny is to be prepared into oral liquid for oral administration or powder or tablet or capsule according to the conventional technology of preparing of Chinese medicine.
Medicine for external use with stifling on the lumbar vertebra position container, is realized the purpose of partner treatment then by conventional method for cooking.
Because the present invention is a Chinese medicine preparation, the active ingredient of preparation all is a Chinese herbal medicine, and the component compatibility is reasonable.It is got through the footpath arteries and veins, repairs affected bone, promotes telangiectasis, improves immune function of human body to regulate the blood flow circulation, thereby reaches the outgrowth purpose of treatment lumbar vertebra.
Caulis Sargentodoxae: be used as medicine with ratan on the Chinese medicine, property is flat, bitter in the mouth, and function heat-clearing and toxic substances removing, promoting blood circulation to restore menstrual flow cure mainly diseases such as arthralgia.
Radix Dipsaci: Radix Dipsaci is the conventional Chinese medicine material, classifies as top gradely in Shennong's Herbal, has invigorating the liver and kidney, bone and muscle strengthening, continuous folding and hinders, ends metrorrhagia, effect such as antiabortive.
Radix Achyranthis Bidentatae: bitter in the mouth, sweet, sour, property is flat.Return liver, kidney channel.Promoting blood circulation to restore menstrual flow, invigorating the liver and kidney, bone and muscle strengthening, relieving stranguria by diuresis, conducting blood to flow downwards.Cure mainly dizziness due to hyperactivity of liver-YANG, soreness of waist and knee joint, muscles and bones is unable, amenorrhea and mass in the abdomen, month is through uncomfortable, puerperal abdonimal pain, arthralgia, traumatic pain, stranguria with blood, edema, dysuria is spitted blood epistaxis.
Cortex erythrinae: flavor is how hot, bitter, warm in nature, cold.Go into the Liver and kidney warp.In this class medicine, the property of medicine of wind-damp-dispelling and cold-dissipating medicinal and wind-damp dispelling bone and muscle strengthening medicine is temperature partially, and the property of medicine of wind-damp-dispelling and heat-clearing medicinal is relatively cold and cool.Its suffering can be dispeled the wind, bitter energy dampness, and temperature energy cold expelling, trembling with fear can heat clearing away.Suffer from the joint muscles and bones of arthralgia pain, wind-damp dispelling, the meridian dredging.Be used for the rheumatism arthromyodynia, lumbocrural pain, numb limbs and tense tendons, the contracture of muscle arteries and veins.
RADIX GENTIANAE MACROPHYLLAE: bitter in the mouth, suffering, cold nature.Return stomach, liver, gallbladder meridian.Effect is used, wind-damp dispelling, stopping numbness pain, reducing the asthenic fever, clearing away damp-heat.Cure mainly rheumatic arthralgia, the contracture of muscle arteries and veins, hands and feet caused by paralysis, osteopyrexia and fever, jaundice due to damp-heat.
Cortex Eucommiae: acrid in the mouth is flat.Warm in nature, nontoxic.Go into liver, kidney channel.The function invigorating the liver and kidney, bone and muscle strengthening, antiabortive.Cure mainly the spinal column ache, foot and knee flaccidity, dribbling urination, uncontrolled urination is itched, and vaginal bleeding during pregnancy is desired to fall, hypertension.Liver and kidney tonifying, the nourishing muscle and tendon bone goes to the joint wet excessive.
Radix Clematidis: acrid in the mouth is salty, and is warm in nature, poisonous.Go into urinary bladder channel.The effect of Radix Clematidis: wind-damp dispelling, the meridian dredging, expectorant saliva, the hypochondriac lump of loosing.Control gout, insensitive impediment, chills and pain of the waist and kness, beriberi, malaria , lumps in the chest and abdomen, tetanus, tonsillitis, all a fishbone or other bone caught in the throat pharynxs.Its property benefaction, so the twelve channels and collaterals that can pass through is particularly suitable to whole body migratory rheumatism pain.
Radix Angelicae Sinensis: sweet in the mouth, suffering, little hardship.Modern study chemical constituent: contain neutral oil compositions such as nopinene, australene, camphene in the Radix Angelicae Sinensis.Contain right-methylbenzyl alcohol, 5-methoxyl group-2, acid-soluble oil composition, organic acid such as 3-xylenols; Saccharide; Vitamin; Aminoacid etc.The effect tonifying blood and regulating menstruation. promoting blood circulation and stopping pain, loosening bowel to relieve constipation.
LUMBRICUS: be commonly called as Lumbricus.The gas raw meat, it is little salty to distinguish the flavor of.Function with cure mainly heat clearing away relieving convulsion, suppressing the hyperactive liver to relieve the wind syndrome, dredge the meridian passage, the diuresis of relievining asthma.It is manic to cure mainly the calentura heating, and infantile convulsion is twitched, headache due to hyperactivity of liver-YANG, apoplectic hemiplegia, rheumatic arthralgia, dyspnea and cough due to lung-heat, diseases such as urinary obstruction.,
Radix Morindae Officinalis: have another name called three MANCAO, acrid-sweet flavor, warm in nature, nontoxic.Go into liver, kidney channel.The effect of Radix Morindae Officinalis, kidney-replenishing, strengthening bone and muscle, wind-damp dispelling.Control sexual impotence, few abdomen cold type of pain, incontinence of urine, deficiency-cold of uterus, anemofrigid-damp arthralgia, soreness of waist and knee joint.
The gold Rhizoma Cibotii: warm in nature, sweet in the mouth, hardship.Return liver, kidney channel.The gold Rhizoma Cibotii is for scar tissue, liver, the swollen dirty damaging hemorrhage anastalsis that has.The hemostasis principle is the result of physical action.The haemostatic effect of powder is best.Pure powder spreading wound surface, foreign body reaction is similar to gelfoam and lighter, can be organized to absorb gradually and disappear.
Rhizoma Drynariae: be rhizome such as Polypodiaceae plant Mongolian oak Herba pteridii latiusculi, drynaria baronii Diels, Semen Nelumbinis Rhizoma Zingiberis Recens Mongolian oak Herba pteridii latiusculi, precipice Rhizoma Zingiberis Recens, the close net Herba pteridii latiusculi of light and Davalliaceae plant Da Ye Rhizoma Drynariae, Rhizoma Drynariae.Bitter in the mouth, warm in nature, nontoxic.Go into liver, kidney channel.The effect of Rhizoma Drynariae: the kidney invigorating, invigorate blood circulation hemostasis.Control suffer from a deficiency of the kidney chronic diarrhea and lumbago, rheumatic arthralgia, toothache, tinnitus, traumatic injury sprain and contusion, bone injury, appendicitis, alopecia areata, diseases such as clavus.
Radix Glycyrrhizae: be the pulse family herbaceos perennial.Sweet in the mouth, property is flat.GUIXIN, lung, spleen, stomach warp.Function cures mainly, invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.Be used for weakness of the spleen and stomach, fatigue and weakness, shortness of breath and palpitation, cough with copious phlegm, gastral cavity abdomen, the anxious pain of extremity contraction, carbuncle sore tumefacting virus, cushion toxicity, strong.
More than each component phase
Figure BSA00000378145400031
Coordinative role.Make this medical instrument that wind-damp dispelling, the meridian dredging, arresting convulsion, pain relieving be arranged, improve effects such as blood circulation.This drug regimen is prepared into oral medicine take after, by each cell tissue delivery of oxygen of blood and various nutrient, remove the blood flow path through obstacle, adjusting blood circulation, active cell tissue and function of human body, improve body immunity, reach the purpose of treatment lumbar vertebra hyperosteogeny disease; With this medicament fumigating waist, can organize by skin surface, enter disease sites, directly act on lumbar vertebra, wind-damp dispelling, the pain that relieves the pain are regulated blood circulation, suppress the development of lumbar vertebra hyperosteogeny disease., external for oral administration this medicine have significant curative effect to treatment lumbar vertebra hyperosteogeny disease, and cure rate reaches more than 90%.
The treatment standard:
The sick treatment standard of typical lumbar vertebra matter hypertrophy: be clearly better in one month, and transferred numbness to by pain, obvious effective rate reaches more than 90%, along with increase the course of treatment, pain, feeling of numbness disappear after three months, and it is controlled to increase sclerotin, patient progressively gets well, and total cure rate reaches more than 90%.
Treatment course of treatment: 10 days is a course of treatment, nine courses of treatment of continuous use.Therapeutic effect: with 2,006 one 2008 be example, accept 24 of lumbar vertebra hyperosteogeny patients in 3 years altogether, after one month (three courses of treatment), transfer 20 numb people to by pain, 15 people that heal three months (nine courses of treatment) entirely, 5 people of healing substantially entirely, only surplus 4 people continue to receive treatment.
Typical case's introduction of falling ill:
1, the bright man of Wang Zhen 58 years old, lives the development zone, Yantai.The cadre, lumbar vertebra hyperosteogeny pain influences operate as normal unbearably, uses this pharmaceutical formulation (for oral administration, external) after the course of treatment, the lumbar vertebra numbness to occur and swell, and after three courses of treatment, pain symptom disappears, and after nine courses of treatment, physical recovery is normal.
2, Xu Honglou man 41 years old, lives Yantai City's Zhifu District, the workman, lumbar vertebra hyperosteogeny pain can not normally be worked unbearably, uses this pharmaceutical formulation (for oral administration, external) after the course of treatment, the numb heating of cervical vertebra occurs, after three courses of treatment, pain symptom disappears, and after nine courses of treatment, physical recovery is normal.
3, Liu Ke English woman 65 years old, lives the development zone, Yantai.The peasant, lumbar vertebra hyperosteogeny pain can not normally be worked unbearably, uses this pharmaceutical formulation (for oral administration, external) after the course of treatment, the cervical vertebra numbness to occur, and after three courses of treatment, pain symptom disappears, and after nine courses of treatment, physical recovery is normal.
The specific embodiment:
Embodiment 1:
With decoction treatment lumbar vertebra hyperosteogeny disease.10 parts of Rhizoma et Radix Araliae Cordatae, 10 parts of Radix Dipsacis, 10 parts of Radix Achyranthis Bidentataes, 25 parts of Cortex erythrinaes, 15 parts of RADIX GENTIANAE MACROPHYLLAEs, 8 parts of Cortex Eucommiaes, 8 parts of Radix Clematidis, 8 parts of Radix Angelicae Sinensis, 8 parts of LUMBRICUS, 10 parts of Radix Morindae Officinaliss, 6 parts of golden Rhizoma Cibotii, 6 parts of Rhizoma Drynariae, 6 parts of Radix Glycyrrhizae.Be prepared into oral liquid for oral administration through extracting active ingredient.After taking, can effectively treat the lumbar vertebra hyperosteogeny disease, reach ideal effect.
Embodiment 2:
With pill treatment lumbar vertebra hyperosteogeny disease.20 parts of Rhizoma et Radix Araliae Cordatae, 20 parts of Radix Dipsacis, 20 parts of Radix Achyranthis Bidentataes, 35 parts of Cortex erythrinaes, 25 parts of RADIX GENTIANAE MACROPHYLLAEs, 14 parts of Cortex Eucommiaes, 15 parts of Radix Clematidis, 15 parts of Radix Angelicae Sinensis, 14 parts of LUMBRICUS, 15 parts of Radix Morindae Officinaliss, 12 parts of golden Rhizoma Cibotii, 12 parts of Rhizoma Drynariae, 12 parts of Radix Glycyrrhizae.The said medicine group is confusingly dried, ground, add Mel, be prepared into pill, per 10 days is a course of treatment, serve on 9 courses of treatment, promptly heals.
Embodiment 3:
With capsule dress powder oral medicine treatment lumbar vertebra hyperosteogeny disease.11 parts of Rhizoma et Radix Araliae Cordatae, 11 parts of Radix Dipsacis, 11 parts of Radix Achyranthis Bidentataes, 26 parts of Cortex erythrinaes, 16 parts of RADIX GENTIANAE MACROPHYLLAEs, 9 parts of Cortex Eucommiaes, 9 parts of Radix Clematidis, 9 parts of Radix Angelicae Sinensis, 9 parts of LUMBRICUS, 11 parts of Radix Morindae Officinaliss, 7 parts of golden Rhizoma Cibotii, 7 parts of Rhizoma Drynariae, 7 parts of Radix Glycyrrhizae.As above Chinese medicine is produced oral medicine according to the production technology of capsule dress powder, and per 10 days is a course of treatment, serve on 9 courses of treatment, promptly heals.
Embodiment 4:
With tablet oral medication lumbar vertebra hyperosteogeny disease.19 parts of Rhizoma et Radix Araliae Cordatae, 19 parts of Radix Dipsacis, 19 parts of Radix Achyranthis Bidentataes, 34 parts of Cortex erythrinaes, 24 parts of RADIX GENTIANAE MACROPHYLLAEs, 13 parts of Cortex Eucommiaes, 14 parts of Radix Clematidis, 14 parts of Radix Angelicae Sinensis, 13 parts of LUMBRICUS, 14 parts of Radix Morindae Officinaliss, 11 parts of golden Rhizoma Cibotii, 11 parts of Rhizoma Drynariae, 11 parts of Radix Glycyrrhizae.As above Chinese medicine is produced the tablet oral medicine according to the conventional production technology of tablet oral medicine, and per 10 days is a course of treatment, serve on 9 courses of treatment, promptly heals.
Embodiment 5:
By fumigation treatment lumbar vertebra hyperosteogeny disease.15 parts of Rhizoma et Radix Araliae Cordatae, 15 parts of Radix Dipsacis, 15 parts of Radix Achyranthis Bidentataes, 30 parts of Cortex erythrinaes, 20 parts of RADIX GENTIANAE MACROPHYLLAEs, 10 parts of Cortex Eucommiaes, 10 parts of Radix Clematidis, 10 parts of Radix Angelicae Sinensis, 10 parts of LUMBRICUS, 10 parts of Radix Morindae Officinaliss, 8 parts of golden Rhizoma Cibotii, 8 parts of Rhizoma Drynariae, 8 parts of Radix Glycyrrhizae.With said medicine component mix homogeneously, add water, be heated to boiling, disease sites is put the handtailor container top directly fumigate, cooperate the endo-medicine treatment.After using, can effectively treat the lumbar vertebra hyperosteogeny disease, reach ideal effect.Per 10 days is a course of treatment (once a day), 9 courses of treatment of continuous fumigation, promptly heals.

Claims (4)

1. a Chinese medicine for the treatment of lumbar vertebra hyperosteogeny is characterized in that, it is that Chinese crude drug by following composition by weight is prepared from: 10 1 20 parts of Rhizoma et Radix Araliae Cordatae, 10 1 20 parts of Radix Dipsacis, 10 1 20 parts of Radix Achyranthis Bidentataes, 25 1 35 parts of Cortex erythrinaes, 15 1 25 parts of RADIX GENTIANAE MACROPHYLLAEs, 8 one 14 parts of Cortex Eucommiaes, 8 one 15 parts of Radix Clematidis, 8 one 15 parts of Radix Angelicae Sinensis, 8 one 14 parts of LUMBRICUS, 10 1 15 parts of Radix Morindae Officinaliss, 6 one 12 parts of golden Rhizoma Cibotii, 6 one 12 parts of Rhizoma Drynariae, 6 one 12 parts of Radix Glycyrrhizae.
2. the Chinese medicine of treatment lumbar vertebra hyperosteogeny according to claim 1 is characterized in that, it is that Chinese crude drug by following composition by weight is prepared from: 11 1 19 parts of Rhizoma et Radix Araliae Cordatae, 11 1 19 parts of Radix Dipsacis, 11 1 19 parts of Radix Achyranthis Bidentataes, 26 1 34 parts of Cortex erythrinaes, 16 1 24 parts of RADIX GENTIANAE MACROPHYLLAEs, 9 one 13 parts of Cortex Eucommiaes, 9 one 14 parts of Radix Clematidis, 9 one 14 parts of Radix Angelicae Sinensis, 9 one 13 parts of LUMBRICUS, 11 1 14 parts of Radix Morindae Officinaliss, 7 one 11 parts of golden Rhizoma Cibotii, 7 one 11 parts of Rhizoma Drynariae, 7 one 11 parts of Radix Glycyrrhizae.
3. the Chinese medicine of treatment lumbar vertebra hyperosteogeny according to claim 1 is characterized in that, it is that Chinese crude drug by following composition by weight is prepared from: 15 parts of Rhizoma et Radix Araliae Cordatae, 15 parts of Radix Dipsacis, 15 parts of Radix Achyranthis Bidentataes, 30 parts of Cortex erythrinaes, 20 parts of RADIX GENTIANAE MACROPHYLLAEs, 10 parts of Cortex Eucommiaes, 10 parts of Radix Clematidis, 10 parts of Radix Angelicae Sinensis, 10 parts of LUMBRICUS, 10 parts of Radix Morindae Officinaliss, 8 parts of golden Rhizoma Cibotii, 8 parts of Rhizoma Drynariae, 8 parts of Radix Glycyrrhizae.
4. according to the Chinese medicine of claim 1 or the described treatment lumbar vertebra hyperosteogeny of 2 or 3 arbitrary claim, it is characterized in that being prepared into oral liquid for oral administration or powder or tablet or capsule according to the conventional technology of preparing of Chinese medicine.
CN2010105792278A 2010-11-26 2010-11-26 Traditional Chinese medicine for treating lumbar hyperosteogeny Pending CN102048863A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010105792278A CN102048863A (en) 2010-11-26 2010-11-26 Traditional Chinese medicine for treating lumbar hyperosteogeny

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010105792278A CN102048863A (en) 2010-11-26 2010-11-26 Traditional Chinese medicine for treating lumbar hyperosteogeny

Publications (1)

Publication Number Publication Date
CN102048863A true CN102048863A (en) 2011-05-11

Family

ID=43953880

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010105792278A Pending CN102048863A (en) 2010-11-26 2010-11-26 Traditional Chinese medicine for treating lumbar hyperosteogeny

Country Status (1)

Country Link
CN (1) CN102048863A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103142715A (en) * 2013-03-13 2013-06-12 于复新 Traditional Chinese medicine preparation for treating lumbar intervertebral disc herniation
CN103751346A (en) * 2014-02-01 2014-04-30 王雪雁 Traditional Chinese medicine composition for lumbocrural pain and numbness caused by lumbar disc herniation operation
CN104825814A (en) * 2015-05-11 2015-08-12 赵振荣 Medicine for treating lumbar hyperosteogeny and preparation method thereof
CN109248238A (en) * 2017-07-14 2019-01-22 苏丽 A kind of preparation and its application of lympha toxin expelling healthy liquid

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101406534A (en) * 2008-11-15 2009-04-15 张向朋 Chinese medicinal decoction for treating hyperosteogeny

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101406534A (en) * 2008-11-15 2009-04-15 张向朋 Chinese medicinal decoction for treating hyperosteogeny

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103142715A (en) * 2013-03-13 2013-06-12 于复新 Traditional Chinese medicine preparation for treating lumbar intervertebral disc herniation
CN103142715B (en) * 2013-03-13 2014-06-25 于复新 Traditional Chinese medicine preparation for treating lumbar intervertebral disc herniation
CN103751346A (en) * 2014-02-01 2014-04-30 王雪雁 Traditional Chinese medicine composition for lumbocrural pain and numbness caused by lumbar disc herniation operation
CN103751346B (en) * 2014-02-01 2016-04-13 青岛华之草医药科技有限公司 A kind of Chinese medicine composition for hernia of lumbar intervertebral disk low back lower limb fiber crops pain
CN104825814A (en) * 2015-05-11 2015-08-12 赵振荣 Medicine for treating lumbar hyperosteogeny and preparation method thereof
CN109248238A (en) * 2017-07-14 2019-01-22 苏丽 A kind of preparation and its application of lympha toxin expelling healthy liquid

Similar Documents

Publication Publication Date Title
CN103520654B (en) A kind of Chinese medicine composition being used for the treatment of knee osteoarthritis and preparation method thereof
CN103656238B (en) A kind of Chinese medicine composition for the treatment of rheumatic osteopathia
CN100551422C (en) A kind of endo-medicine for the treatment of intervertebral disk hernia
CN102793883A (en) Plaster for treating intervertebral disc protrusion, cervical spondylosis and osteoproliferation
CN110038075A (en) A kind of fomentation medicine composition and preparation method thereof
CN102008610B (en) Traditional Chinese medicine composition for curing hyperosteogeny
CN102846966A (en) A medicine for expelling pathogenic wind, relieving pain and resisting hyperosteogeny
CN104353019A (en) Traditional Chinese medicine hot compress bag with meridian dredging and internal organ conditioning functions and preparation method of traditional Chinese medicine hot compress bag
CN102048863A (en) Traditional Chinese medicine for treating lumbar hyperosteogeny
CN102028901B (en) Traditional Chinese medicine for treating knee joint hypertrophic synovitis
CN103751427B (en) A kind of precious jade medicine treating radius far-end fracture
CN102018821B (en) Chinese medicament for treating hypertrophic rachitis
CN101690779B (en) Traditional Chinese medicine for oral taking for treating scapulohumeral periarthritis
CN102028768B (en) Traditional Chinese medicament for treating lumbar canal stenosis
CN104940863A (en) Medical dressing paste for treating sciatica
CN1994380B (en) Externally applied medicine for treating arthritis, hot pack and preparation method thereof
CN104524080A (en) Traditional Chinese medicine preparation for treating injuries from falls, fractures, contusions and strains and preparation method
CN103751467A (en) Traditional Chinese medicine composition for treating lumbar and back myofascitis and preparation method thereof
CN102028887B (en) Traditional Chinese medicine for treating hyperplasia of cervical vertebra
CN102028810B (en) Traditional Chinese medicine for treating lumbar intervertebral disc protrusion
CN102018792B (en) Traditional Chinese medicine for treating ankylosing spondylitis
CN102078588B (en) Medicinal composition for treating osteoproliferation and preparation method thereof
CN100396305C (en) Chinese medicinal preparation for treating hyperosteogeny and lumbar vertebra protrusion
CN100435833C (en) Medicine for treating Bi syndrome and method for preparing same
CN105362944A (en) Traditional Chinese medicine ointment for treating orthopedics sprain and contusion

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20110511